Cargando…
Ruthenium-106 plaque radiotherapy for uveal melanoma: analysis of tumor dimension and location on anatomical and functional results
BACKGROUND: To report the long-term outcomes of Ru-106 plaque radiotherapy in eyes with uveal melanoma (UM) and to assess the effect of tumor thickness and location on final outcomes. METHODS: Medical records of 234 patients undergoing Ru-106 plaque radiotherapy for UM were reviewed, and the visual...
Autores principales: | Mirshahi, Reza, Sedaghat, Ahad, Jaberi, Ramin, Azma, Zohreh, Mazloumi, Mehdi, Naseripour, Masood |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288719/ https://www.ncbi.nlm.nih.gov/pubmed/35842619 http://dx.doi.org/10.1186/s12886-022-02521-9 |
Ejemplares similares
-
Ruthenium-106 brachytherapy for thick uveal melanoma: reappraisal of apex and base dose radiation and dose rate
por: Naseripour, Masood, et al.
Publicado: (2016) -
Short-term changes of cornea and tear film after ruthenium-106 plaque therapy for intraocular tumors
por: Aghaei, Hossein, et al.
Publicado: (2021) -
Brachytherapy of Uveal Melanomas with Ruthenium-106 Plaques
por: Belaïd, Asma, et al.
Publicado: (2016) -
Treatment Outcome of Acquired Retinal Pigment Epithelial Tumors with Rhuthenium-106 Plaque Radiotherapy: Experience on Two Cases
por: Naseripour, Masood, et al.
Publicado: (2020) -
(106)Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma
por: Jiang, Ping, et al.
Publicado: (2020)